Fast Market Research

New Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014

New Pharmaceuticals market report from Global Markets Direct: "Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014"


Boston, MA -- (SBWIRE) -- 04/14/2014 -- Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD)'s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and special features on late-stage and discontinued projects.

View Full Report Details and Table of Contents

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides a snapshot of the global therapeutic landscape of Chronic Obstructive Pulmonary Disease (COPD)
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Chronic Obstructive Pulmonary Disease (COPD) and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Chronic Obstructive Pulmonary Disease (COPD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

Companies Mentioned in this Report: Johnson & Johnson, Boehringer Ingelheim GmbH, Kyowa Hakko Kirin Co., Ltd., Osiris Therapeutics, Inc., AstraZeneca PLC, GlaxoSmithKline plc, MedImmune, LLC, Daiichi Sankyo Company, Limited, Merck & Co., Inc., Dainippon Sumitomo Pharma Co., Ltd., Grifols, S.A., Bioneer Corporation, Takeda Pharmaceutical Company Limited, SkyePharma PLC, Novartis AG, ASKA Pharmaceutical Co., Ltd., Astellas Pharma Inc., Chiesi Farmaceutici SpA, Kissei Pharmaceutical Co., Ltd., Laboratoires Pierre Fabre SA, Meda AB, Orion Oyj, Pfizer Inc., Ranbaxy Laboratories Limited, Teva Pharmaceutical Industries Limited, Zambon Company S.p.A., OPKO Health, Inc., Alchemia Limited, Almirall, S.A., Lupin Limited, Basilea Pharmaceutica AG, Medivir AB, Pharmaxis Limited, Cytokinetics, Incorporated, Yungjin Pharm Ind. Co., Ltd., Yuhan Corporation, Dynavax Technologies Corporation, Bioxyne Limited, Torrent Pharmaceuticals Limited, Dongwha Pharm Co., Ltd., Biotie Therapies Corp., Seoul Pharma Co., Ltd., Neurim Pharmaceuticals Ltd, Theravance, Inc., Synairgen plc, Galapagos NV, Orexo AB, Sucampo Pharmaceuticals, Inc., Proteo, Inc., Verona Pharma Plc, Advinus Therapeutics Ltd., Alba Therapeutics Corporation, Respiratorius AB, Ache Laboratorios Farmaceuticos S/A, Aquinox Pharmaceuticals Inc., Nostrum Pharmaceuticals, LLC, Promedior, Inc., Pulmatrix, Inc., Axikin Pharmaceuticals, Inc., Syntrix Biosystems, Inc., MSM Protein Technologies, Inc., AIM Therapeutics Inc., Hydra Biosciences, Inc., Theraclone Sciences, Inc., Polyphor Ltd., Concert Pharmaceuticals, Inc., Noxxon Pharma AG, TransTech Pharma, Inc., Edmond Pharma Srl, Cempra, Inc., KaloBios Pharmaceuticals, Inc., Adamis Pharmaceuticals Corporation, SuppreMol GmbH, Medestea Research & Production S.p.A., Ikaria Inc., Stelic Institute & Co., Asmacure Ltee, Protagonist Therapeutics Inc., MicroDose Therapeutx, Inc., SelectX Pharmaceuticals, Inc., iCeutica, Inc., Otsuka Holdings Co., Ltd., Beech Tree Labs, Inc., N30 Pharmaceuticals, Errant Gene Therapeutics, LLC, GlycoMar Limited, Stempeutics Research Private Limited, AlgiPharma AS, Clarassance, Inc., Ampio Pharmaceuticals, Inc., Spring Bank Pharmaceuticals, Inc., Selvita S.A, Apellis Pharmaceuticals, Inc., Corridor Pharmaceuticals Inc., Amakem NV, Microbion Corporation, Rottapharm|Madaus, Sunovion Pharmaceuticals Inc., P2D Bioscience, PharmaLundensis AB, Visionary Pharmaceuticals, Inc., Qu Biologics Inc., sterna biologicals Gmbh & Co KG, Rhizen Pharmaceuticals SA, Panmira Pharmaceuticals, LLC., Carolus Therapeutics, Inc., Foresee Pharmaceuticals, LLC, Peptinnovate Limited, vida therapeutics inc., Dong-A Socio Holdings Co Ltd, Ario Pharma Ltd

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2013
- Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H2, 2013
- Parkinson's Disease - Pipeline Review, H1 2014
- Alzheimer's Disease - Pipeline Review, H1 2014
- Crohn's Disease - Pipeline Review, H1 2014
- Huntington's Disease - Pipeline Review, H1 2014
- Chronic Heart Failure - Pipeline Review, H1 2014
- Chronic Bronchitis - Pipeline Review, H1 2014
- Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014
- Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2014